CEUS Evaluation of Hydrocephalus in Neonates and Infants

NCT06693752 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hydrocephalus in Infants
Hydrocephalus Acquired

Interventions

DRUG: Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]

Sponsor

Children's Hospital of Philadelphia